Kirov pharma cluster participants explored biotech development in France

| By | Localization, Nanolek, Pharmclusters, Sanofi, Vaccine Production

The delegation of the Kirov region government visited the Lyonbiopôle in France, the largest pharmaceutical cluster in the world. During the visit, the governor of the Kirov region Igor Vasiliev presented Kirov biotechnology cluster to the leaders of Lyon Metropolis.

According to the strategy of socio-economic development of the Kirov region until 2020, the development of biotech and biopharmaceuticals is a key area for the industrial sector of the region. This is the reason why the government of the region is interested to share the experience in the establishment of clusters and seeks a long-term cooperation with the French Republic.

“The establishment of an industrial cluster is a real opportunity for local production of medicines in the Kirov region, which will be much cheaper than imported ones, create new high-tech jobs, and train highly qualified specialists. We have all the conditions to accomplish this. This will improve the investment attractiveness of the region and raise additional federal funding. The experience of the Lyon Metropolis will be helpful for full-scale implementation of these plans, because this is a place where biotechnology have been developing successfully for several decades within a cluster,” said Igor Vasiliev.


For their part, the representatives of the management of Sanofi Pasteur, a French company, mentioned the successful implementation of a joint localization project for manufacturing vaccines at the Nanolek production site in the Kirov region and discussed the possibility of launching several more joint projects.

“In 2021, after complete transfer of manufacturing technology and quality control systems, we plan to start producing a finished dosage form of vaccine at the Nanolek site with a projected annual output of 8-10 million doses. During the entire work on the project, we felt the interest and support from the leadership of the region and personally from the governor Igor Vasiliev, which we appreciate very much. We are confident that the project on localization of our combined five-component vaccine is a significant contribution of our company both to raising the investment attractiveness of the Kirov region and achieving the main goal of Sanofi Pasteur, which is to protect all Russian children from dangerous infections,” said Guillaume Oshalter, General Manager of Sanofi Pasteur Russia and Belarus.

SOURCE: kirov region
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.